Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: CONSUN PHARMA(01681) the Revenue is 1.03 B (+19.97%);the EBIT is 382.98 M (+35.94%);the EPS is 0.404 (+27.26%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
1.03B19.97%
----
----
EBIT
0.38B35.94%
----
----
EPS
0.403927.26%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf